tm logo
QREYDO
REGISTERED

on 18 Oct 2024

Last Applicant/ Owned by

Boehringer Ingelheim International GmbH

55218 Ingelheim

DE

Serial Number

2159822 filed on 24th Sep 2021

Registration Number

TMA1263978 registered on 18th Oct 2024

Registration expiry Date

24th Sep 2031

Correspondent Address

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

QREYDO

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, and respiratory system; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the genitourinary system, namely, genitourinary diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics, anti-infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely cell-based immune therapeutics for treatment of cancer, treatment of immunological diseases, and treatment of viral infections.


Classification kind code

11

Mark Details


Serial Number

2159822

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 21st Jun 2024
Agent Changed
Submitted for opposition 22
on 18th Apr 2023
Search Recorded
Submitted for opposition 20
on 18th Apr 2023
Examiner's First Report
Submitted for opposition 223
on 18th Apr 2023
Total Provisional Refusal
Submitted for opposition 256
on 14th Nov 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 13th Jan 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 12th Jan 2022
Created
Submitted for opposition 31
on 12th Jan 2022
Formalized
Submitted for opposition 30
on 24th Sep 2021
Filed
Submitted for opposition 228
on 24th Sep 2021
International Registration